topotecan has been researched along with serine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, W; Darzynkiewicz, Z; Halicka, HD; Huang, X; Kurose, A; Tanaka, T; Traganos, F | 1 |
Darzynkiewicz, Z; Traganos, F; Zhao, H | 1 |
Gjerset, RA; Zhao, M | 1 |
3 other study(ies) available for topotecan and serine
Article | Year |
---|---|
Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Caffeine; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cytoplasm; DNA-Binding Proteins; Flow Cytometry; Histones; HL-60 Cells; Humans; Immunohistochemistry; Interphase; Kinetics; Mitoxantrone; Phosphorylation; Protein Serine-Threonine Kinases; Serine; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topoisomerase Inhibitors; Topotecan; Tumor Suppressor Proteins | 2005 |
Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Checkpoint Kinase 2; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Mitoxantrone; Phosphorylation; Protein Serine-Threonine Kinases; Serine; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2008 |
Topoisomerase-I PS506 as a Dual Function Cancer Biomarker.
Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colonic Neoplasms; DNA Topoisomerases, Type I; Female; Gene Expression; Humans; Irinotecan; Lung; Lung Neoplasms; Molecular Sequence Data; Neoplasms; Ovarian Neoplasms; Phosphorylation; Serine; Topotecan | 2015 |